Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trial

FOCUS

Update on Pregart clinical trial participant recruitment as of 13th October 2021

The Ugandan team started participant recruitment on 21st September 2021, with a total of 8 participants recruited to date. Prior to recruitment we…

Hawassa University Pregart clinical trial project PhD candidates presented their thesis concept note

One of the Pregart clinical trial project deliverable is clinical trial capacity building in Africa.  Accordingly, one of the project consortium…

Hawassa University President welcome Pregart clinical trial investigators

Hawassa University president, Dr. Ayano Beraso, warmly welcome Pregart clinical trial investigators on September 20/2021 at the president office. The…

Pregart project investigators conducted trial hospital site visit

Professor Eleni Aklilu from Karolinska institute, Professor Eyasu Mekonnen from Addis Ababa university with Hawassa University trial lead team…

Pregart clinical trial Ethiopia trial lead team conducted project implementation status review meeting

A two-day review meeting, September 21-22/2021, was conducted on the Ethiopia Pregart clinical trial implementation status at the University project…

Pregart clinical trial project in Ethiopia has started participant recruitment in the third trial site

After the long impact of Covid-19 pandemic to the clinical trial implementation timeline, the Hawassa University trial lead team conducted site…

PREGART video presentation

DOCUMENTS

Short facts

PREGART brief description

DOWNLOAD PDF

Impact

Impact of PREGART project

DOWNLOAD PDF

The project

Full description of PREGART project

DOWNLOAD PDF

Work packages

Work packages of PREGART project

DOWNLOAD PDF